Evidence map›Paper›PMID 36677442›Full record

ArticleMicroorganisms2023

Antibacterial Activity of a Natural Clay Mineral against

Shekooh Behroozian, James E A Zlosnik, Wanjing Xu, Loretta Y Li, Julian E Davies

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Design and Evaluation of aPharmaceutics · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Annals of medicine · 2024
    Review
  6. Antibacterial and Antioxidant Activities, Toxicity, and Physicochemical Properties ofAdvances in pharmacological and pharmaceutical sciences · 2024
    Article
  7. Romanian Wild-GrowingAntioxidants (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Shekooh BehroozianDepartment of Chemical and Biological Engineering, University of British Columbia, 2360 E Mall, Vancouver, BC V6T 1Z3, Canada.ORCID 0000-0002-3855-9059
James E A ZlosnikCentre for Understanding and Preventing Infection in Children, Division of Infectious Diseases, Department of Pediatrics, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, BC V5Z 4H4, Canada.
Wanjing XuDepartment of Civil Engineering, University of British Columbia, 6250 Applied Science Ln, Vancouver, BC V6T 1Z3, Canada.
Loretta Y LiDepartment of Civil Engineering, University of British Columbia, 6250 Applied Science Ln, Vancouver, BC V6T 1Z3, Canada.
Julian E DaviesDepartment of Microbiology and Immunology, University of British Columbia, 2350 Health Sciences Mall, Vancouver, BC V6T 1Z3, Canada.
University of British Columbia · CA

Funding

Cystic Fibrosis Canada 20R67183MITACS Canada 22R07416Tally Fund NA
6 · The paper itself

Abstract

There is an impending crisis in healthcare brought about by a new era of untreatable infections caused by bacteria resistant to all available antibiotics. Thus, there is an urgent need to identify novel antimicrobial agents to counter the continuing threat posed by formerly treatable infections. We previously reported that a natural mineral clay known as Kisameet clay (KC) is a potent inhibitor of the organisms responsible for acute infections. Chronic bacterial infections present another major challenge to treatment by antimicrobials, due to their prolonged nature, which results in repeated exposure to antibiotics and a constant selection for antimicrobial resistance. A prime example is bacteria belonging to the

Indexed as

antibacterial activityBurkholderia cepacia complex (Bcc)chronic lung infectionscystic fibrosisnatural clay mineralPseudomonas aeruginosaStenotrophomonas maltophilia

Identifiers

PMID36677442
PMCPMC9862493
OpenAlexW4313824852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.